<p>Envoy Medical Inc. 宣布其针对实验性全植入 Acclaim® 耳蜗植入体的关键临床研究已达到全招募目标的中期。公司报告称，招募工作正在稳步推进，预计将在 2026 年第一季度的上半年内完成。Acclaim® 耳蜗植入体旨在利用专有的植入式压电传感器，通过自然耳朵捕捉声音，而不是依赖外部麦克风。关键研究的结果尚未公布，预计将在招募完成及后续试验阶段后提供。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。尽管 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Envoy Medical Inc. 于 2025 年 12 月 18 日通过 Newsfile 发布了用于生成本新闻简报的原始内容（参考 ID：278490），并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司（PUBT）</p>

COCH

<p>Envoy Medical Inc. 已经完成其关键性 Acclaim® 人工耳蜗试验的中期招募，目标是在 2026 年初完成。该植入物使用压电传感器自然捕捉声音。结果在招募后待公布。此 AI 生成的简报仅供信息参考，不构成财务建议</p>

<p>Envoy Medical Inc. announced that its pivotal clinical study for the investigational fully implanted Acclaim® cochlear implant has reached the midway point of its full enrollment target. The company reports that enrollment is progressing steadily and remains on track for completion within the first half of the first quarter of 2026. The Acclaim® cochlear implant is designed to utilize a proprietary implanted piezoelectric sensor to capture sound through the natural ear, rather than relying on an external microphone. Results from the pivotal study have not yet been presented and are expected to be available following the completion of enrollment and subsequent phases of the trial. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 278490) on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>
<div class="lb-trans"><p>Envoy Medical Inc. 宣布其针对实验性全植入 Acclaim® 耳蜗植入体的关键临床研究已达到全招募目标的中期。公司报告称，招募工作正在稳步推进，预计将在 2026 年第一季度的上半年内完成。Acclaim® 耳蜗植入体旨在利用专有的植入式压电传感器，通过自然耳朵捕捉声音，而不是依赖外部麦克风。关键研究的结果尚未公布，预计将在招募完成及后续试验阶段后提供。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。尽管 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Envoy Medical Inc. 于 2025 年 12 月 18 日通过 Newsfile 发布了用于生成本新闻简报的原始内容（参考 ID：278490），并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司（PUBT）</p>
</div>

Envoy Medical 在关键的 Acclaim 人工耳蜗植入试验中达到了入组的里程碑